To consider and approve unaudited Financial Statement (Standalone and consolidated) for quarter and nine months ended 31st December, 2024 To consider and declare Interim Dividend at the rate of Rs. 3.00/- per share on face value of Rs. 10.00/- per share for FY 2024-2025.

pdf

Sharda Cropchem Ltd.

21 Jan 2025

868.25

-2.60%

Company Update

Sharda Cropchem Ltd - 538666 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

The Company has scheduled a Conference call for analyst and investors on Friday, 24th January, 2025 at 05.30 P.M. IST.

pdf

Sharda Cropchem Ltd.

16 Jan 2025

868.25

-2.60%

Board Meeting

Sharda Cropchem Ltd - 538666 - Board Meeting Intimation for Consideration And Approval Of The Standalone …

BSE India

Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to consider and approve and take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2024 and to consider & declare Interim Dividend, if any, on the paid-up equity share capital of the Company for the Financial Year 2024-25.

pdf

Sharda Cropchem Ltd.

09 Jan 2025

868.25

-2.60%

Company Update

Sharda Cropchem Ltd - 538666 - Submission Of Statement Of Grievance Redressal Mechanism Under Regulation 13(3) …

BSE India

Statement of Grievance Redressal Mechanism under Regulation 13(3) of SEBI LODR Regulation 2015

pdf

Sharda Cropchem Ltd.

07 Jan 2025

868.25

-2.60%

Company Update

Sharda Cropchem Ltd - 538666 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI DP Regulations, 2018 for quarter ended 31st December, 2024

pdf

Sharda Cropchem Ltd.

27 Dec 2024

868.25

-2.60%

SAST

Sharda Cropchem Ltd - 538666 - Closure of Trading Window

BSE India

Trading window will be closed from 1st January, 2025 till 48 hours from conclusion of Board Meeting for approval of Unaudited Financial Result (Standalone and Consolidated) for quarter and nine months ended 31st December, 2024.

pdf